RGRongqi Guo

Rongqi Guo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rongqi Guo has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • Hao Wang

    Department of Thoracic Surgery, Affiliated Hospital 6 of Nantong University, Medical School of Nantong University, Nantong, China

    2 shared publications
  • Jianxiang Song

    Department of Thoracic Surgery, Affiliated Hospital 6 of Nantong University, Yancheng Third People's Hospital, Yancheng 224000, PR China

    2 shared publications
  • Xia Li

    Department of General Medicine, Yancheng Third People’s Hospital, Affiliated Hospital 6 of Nantong University, Yancheng, PR China

    2 shared publications
  • Yangyang Li

    Department of Thoracic Surgery, Affiliated Hospital 6 of Nantong University, Medical School of Nantong University, Nantong, China

    2 shared publications
  • Yihao Wang

    Department of Thoracic Surgery, Affiliated Hospital 6 of Nantong University, Medical School of Nantong University, Nantong, China

    2 shared publications
  • Rui Wang

    Department of Thoracic Surgery, Affiliated Hospital 6 of Nantong University, Medical School of Nantong University, Nantong, PR China

    1 shared publication

Latest Publications

  • Open Access

    G protein-coupled receptor 137B drives malignant progression and May serves as a diagnostic and prognostic biomarker in esophageal squamous cell carcinoma

    by Rongqi Guo, Yangyang Li, Zhongquan Yi, Weisong Zhang, Hao Wang, Yihao Wang, Xia Li, Jianxiang Song

    G protein-coupled receptors (GPCRs) are widely involved in cell signal transduction, and their abnormal activation has been proved to be closely related to

  • Open Access

    Macrophage Polarisation in the Tumour Microenvironment: Recent Research Advances and Therapeutic Potential of Different Macrophage Reprogramming

    by Rongqi Guo, Rui Wang, Weisong Zhang, Yangyang Li, Yihao Wang, Hao Wang, Xia Li, Jianxiang Song

    Background: Macrophages are a critical component of the innate immune system, derived from monocytes, with significant roles in anti-inflammatory and anti-tumour activities. In the tumour microenvironment, however, macrophages are often reprogrammed into tumour-associated macrophages (TAMs), which promote tumour growth, metastasis, and therapeutic resistance. Purpose: To review recent advancements in the understanding of macrophage polarisation and reprogramming, highlighting their role in tumour progression and potential as therapeutic targets. Research Design: This is a review article synthesising findings from recent studies on macrophage polarisation and reprogramming in tumour biology. Study Sample: Not applicable (review of existing literature). Data Collection and/or Analysis: Key studies were identified and summarised to explore mechanisms of macrophage polarisation and reprogramming, focusing on M1/M2 polarisation, metabolic and epigenetic changes, and pathway regulation. Results: Macrophage reprogramming in the tumour microenvironment involves complex mechanisms, including phenotypic and functional alterations. These processes are influenced by M1/M2 polarisation, metabolic and epigenetic reprogramming, and various signalling pathways. TAMs play a pivotal role in tumour progression, metastasis, and therapy resistance, making them prime targets for combination therapies. Conclusions: Understanding the mechanisms underlying macrophage polarisation and reprogramming offers promising avenues for developing therapies to counteract tumour progression. Future research should focus on translating these insights into clinical applications for effective cancer treatment.